THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 152 filers reported holding THERAPEUTICSMD INC in Q1 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,000 | -99.9% | 10,710 | -98.3% | 0.00% | -100.0% |
| Q1 2019 | $3,052,000 | +27.8% | 626,728 | 0.0% | 0.02% | +25.0% |
| Q4 2018 | $2,388,000 | +12.2% | 626,728 | +93.2% | 0.02% | +42.9% |
| Q3 2018 | $2,128,000 | +958.7% | 324,318 | +683.8% | 0.01% | – |
| Q1 2018 | $201,000 | -54.4% | 41,378 | -43.5% | 0.00% | -100.0% |
| Q4 2017 | $441,000 | +9.2% | 73,198 | -4.1% | 0.00% | 0.0% |
| Q3 2017 | $404,000 | -7.1% | 76,333 | -7.6% | 0.00% | 0.0% |
| Q2 2017 | $435,000 | -12.7% | 82,575 | +19.5% | 0.00% | 0.0% |
| Q1 2017 | $498,000 | +138.3% | 69,127 | +90.5% | 0.00% | 0.0% |
| Q4 2016 | $209,000 | +99.0% | 36,290 | +135.9% | 0.00% | – |
| Q3 2016 | $105,000 | +7.1% | 15,386 | +33.6% | 0.00% | – |
| Q2 2016 | $98,000 | +50.8% | 11,513 | +7.7% | 0.00% | – |
| Q1 2015 | $65,000 | -65.8% | 10,689 | -70.7% | 0.00% | -100.0% |
| Q4 2013 | $190,000 | +341.9% | 36,421 | +147.5% | 0.00% | – |
| Q3 2013 | $43,000 | – | 14,713 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 1492 Capital Management LLC | 369,482 | $2,306,000 | 1.65% |
| SANDERS MORRIS HARRIS LLC | 437,010 | $2,727,000 | 1.26% |
| ARDSLEY ADVISORY PARTNERS LP | 700,000 | $4,368,000 | 0.66% |
| MORGENS WATERFALL VINTIADIS & CO INC | 112,000 | $699,000 | 0.50% |
| CORRADO ADVISORS, LLC | 72,185 | $450,000 | 0.27% |
| Redmond Asset Management, LLC | 101,309 | $632,000 | 0.27% |
| OUTFITTER ADVISORS, LTD. | 51,532 | $322,000 | 0.15% |
| Mengis Capital Management, Inc. | 34,500 | $215,000 | 0.13% |
| GREENWOOD CAPITAL ASSOCIATES LLC | 86,643 | $541,000 | 0.12% |
| Affiance Financial, LLC | 25,050 | $156,000 | 0.12% |